Ledifos

Product Description

1. Ledifos is combination of Ledipasvir and Sofosbuvir.
2. Ledifos is indicated for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection.
3. Ledifos is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration.
   

Description

• Brand Name: Ledifos Tablets
• Contents : Ledipasvir and Sofosbuvir
• Manufactured by : Hetero Healthcare Limited
• Form: Tablets
• Strength: Ledipasvir 90 mg and Sofosbuvir 400 mg
• Packing: Pack of 28 tablets

WARNING:
Ledifos is a prescription drug and should be used under proper medical guidance and advice.The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.